NCT05412069View on ClinicalTrials.gov

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

NARecruitingINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

March 31, 2027

Conditions
Normal SubjectsFecal Incontinence
Interventions
DEVICE

Fecobionics

Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry, balloon expulsion test, and anal ultrasonography will be used as reference.

Trial Locations (2)

30912

RECRUITING

Augusta University Medical Center, Augusta

92121

ACTIVE_NOT_RECRUITING

California Medical Innovations Institute, San Diego

All Listed Sponsors
collaborator

Augusta University Medical Center

UNKNOWN

lead

The California Medical Innovations Institute, Inc.

OTHER